大型抑郁症综述:内分泌系统作为治疗的潜在目标
Sergio Zarazúa-Guzmán1, Jorge Genaro Vicente-Martínez2, Juan Manuel Pinos-Rodríguez2
1Laboratorio de Neurotoxicología, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico.
Basic & clinical pharmacology & toxicology
|October 6, 2024
概括
大型抑郁症影响全球数以百万计的人. 大麻素 (CBD) 显示出作为一种新型治疗方法的前景,针对抑郁症治疗的内分泌大麻素系统.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 重度抑郁症 (MDD) 是一种普遍存在的精神疾病,具有重大的全球影响.
- 不完全了解MDD病理生理学和低缓解率需要新的治疗策略.
- 内分泌大麻素系统与抑郁症有关,这表明调制是治疗途径.
研究的目的:
- 审查和对比当前关于大麻素 (CBD) 管理和大抑郁症中药理学的证据.
- 根据现有研究,评估CBD作为MDD治疗剂的潜力.
- 探索CBD对重大抑郁症病理途径的作用机制.
主要方法:
- 对治疗抑郁症的CBD临床前 (生物模型) 和临床试验数据的系统审查.
- 分析CBD的药理性质,包括其对内分泌系统的影响.
- 将CBD观察到的效应与已知的MDD病理生理机制进行比较.
主要成果:
- 大麻二醇 (CBD) 在各种模型中表现出神经保护性,抗炎性和止痛性.
- 有证据表明,CBD在临床前抑郁症模型中具有潜在的疗效.
- 关于CBD治疗MDD的临床数据正在出现,需要进一步调查.
结论:
- 大麻 (CBD) 是一种有前途的治疗候选物,用于重度抑郁症.
- 需要进一步的研究来阐明CBD的精确机制,并优化其在MDD中的临床应用.
- 用CBD等化合物准内分泌系统为治疗抑郁症提供了一种新的方法.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
200
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
200
Depression: Overview
224
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
224
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
203
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
203
G-protein Coupled Receptors
116.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
116.9K
Long-term Depression
30.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.7K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
167
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
167


